GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sienna Biopharmaceuticals SNNAQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Sienna Biopharmaceuticals — daily SNNAQ Delayed
Market value
$3,091
Last close × shares
Volume
100
Shares, 30 Oct 2026

About Sienna Biopharmaceuticals

Its shares trade under the ticker SNNAQ. It has been listed since 27 July 2017.

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. The company is headquartered in Westlake Village, California. The company went IPO on 2017-07-27. The firm is focused on developing multi-asset pipeline of topical therapies that enhance the health, appearance of life of dermatology patients. The company also advancing multiple product candidates derived from Topical by Design platform, all of which are designed to be suitable for chronic administration in patients with inflammatory skin diseases and other dermatologic and aesthetic conditions. It's SNA-120 is a first-in-class inhibitor of Tropomyosin receptor kinase A, or TrkA, in Phase IIb clinical development for the treatment of pruritus, or itch, associated with psoriasis, as well as for psoriasis itself. It's SNA-125 is a topical Janus kinase 3 (JAK3)/TrkA inhibitor with the potential to treat various inflammatory conditions, including atopic dermatitis, psoriasis and pruritus. Nonclinical studies have demonstrated anti-inflammatory activity in an animal model, and a favorable safety profile.

Figures and description from our data supplier, not checked against the company's own report.

More about Sienna Biopharmaceuticals →

Latest on Sienna Biopharmaceuticals

Our reporting

We have not reported on Sienna Biopharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Sienna Biopharmaceuticals's ticker?

Sienna Biopharmaceuticals trades as SNNAQ on its US listing, under ISIN US82622H1086.

What was Sienna Biopharmaceuticals's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.